Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (4): 50-54.doi: 10.6040/j.issn.1671-7554.0.2021.1525
LI Honghao1, YU Jing2, CHEN Yali1, GUO Shougang1
CLC Number:
[1] Hor JY, Asgari N, Nakashima I, et al. Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide [J]. Front Neurol, 2020, 11: 501. doi: 10.3389/fneur.2020.00501. eCollection 2020. [2] Wu Y, Zhong L, Geng J. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models [J]. Mult Scler Relat Disord, 2019, 27: 412-418. doi:10.1016/j.msard.2018.12.002. [3] Glick AB, Wodzinski A, Fu P, et al. Impairment of regulatory T-cell function in autoimmune thyroid disease [J]. Thyroid, 2013, 23(7): 871-878. [4] Tao JH, Cheng M, Tang JP, et al. Foxp3, Regulatory T cell, and Autoimmune Diseases [J]. Inflammation, 2017, 40(1): 328-339. [5] Bergot AS, Buckle I, Cikaluru S, et al. Regulatory T cells induced by single-peptide liposome immunotherapy suppress islet-specific t cell responses to multiple antigens and protect from autoimmune diabetes [J]. J Immunol, 2020, 204(7): 1787-1797. [6] Wang Y, Zhou Y, Sun X, et al. Cytokine and chemokine profiles in patients with neuromyelitis optica spectrum disorder [J]. Neuroimmunomodulation, 2016, 23(5-6): 352-358. [7] Zhong X, Wang H, Dai Y, et al. Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica [J]. J Neuroimmunol, 2011, 240-241: 104-108. doi: 10.1016/j.jneuroim.2011.10.001. [8] Yang X, Peng J, Huang X, et al. Association of circulating follicular helper t cells and serum cxcl13 with neuromyelitis optica spectrum disorders [J]. Front Immunol, 2021,12: 677190. doi: 10.3389/fimmu.2021.677190. [9] Tanaka M, Matsushita T, Tateishi T, et al. Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis [J]. Neurology, 2008, 71(13): 974-981. [10] Vaknin-Dembinsky A, Brill L, Kassis I, et al. T-cell reactivity against AQP4 in neuromyelitis optica [J]. Neurology, 2012, 79(9): 945-946. [11] Attias M, Al-Aubodah T, Piccirillo CA. Mechanisms of human FoxP3(+)Treg cell development and function in health and disease [J]. Clin Exp Immunol, 2019, 197(1): 36-51. [12] Kato R, Sumitomo S, Tsuchida Y, et al. CD4(+)CD25(+)LAG3(+)T cells with a feature of th17 cells associated with systemic lupus erythematosus disease activity [J]. Front Immunol, 2019, 10: 1619. doi: 10.3389/fimmu.2019.01619. [13] Danikowski KM, Jayaraman S, Prabhakar BS. Regulatory T cells in multiple sclerosis and myasthenia gravis [J]. J Neuroinflammation, 2017, 14(1): 117. [14] Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3 [J]. Science, 2003, 299(5609): 1057-1061. [15] Fathima N, Narne P, Ishaq M. Association and gene-gene interaction analyses for polymorphic variants in CTLA-4 and FOXP3 genes: role in susceptibility to autoimmune thyroid disease [J]. Endocrine, 2019, 64(3): 591-604. [16] Zhang Y, Zhang J, Liu H, et al. Meta-analysis of FOXP3 gene rs3761548 and rs2232365 polymorphism and multiple sclerosis susceptibility [J]. Medicine(Baltimore), 2019, 98(38): e17224. [17] Yang C, Huang XR, Fung E, et al. The regulatory T- cell transcription factor Foxp3 protects against crescentic glomerulonephritis [J]. Sci Rep, 2017, 7(1): 1481. [18] Attias M, Al-Aubodah T, Piccirillo CA. Mechanisms of human FoxP3(+)T(reg)cell development and function in health and disease [J]. Clin Exp Immunol, 2019, 197: 36-51. doi: 10.1111/cei.13290. [19] Zheng SG, Wang JH, Gray JD, et al. Natural and induced CD4+CD25+ cells educate CD4+CD25-cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10 [J]. J Immunol, 2004, 172(9): 5213-5221. [20] Nie J, Li YY, Zheng SG, et al. FOXP3(+)Treg cells and gender bias in autoimmune diseases [J]. Front Immunol, 2015, 6: 493. doi: 10.3389/fimmu.2015.00493. [21] Kiernan MG, Coffey JC, Sahebally SM, et al. Systemic molecular mediators of inflammation differentiate between crohns disease and ulcerative colitis, implicating threshold levels of IL-10 and relative ratios of pro-inflammatory cytokines in therapy [J]. J Crohns Colitis, 2020, 14(1): 118-129. [22] Gran F, Kerstan A, Serfling E, et al. Current developments in the immunology of psoriasis [J]. Yale J Biol Med, 2020, 93(1): 97-110. [23] Kasat K, Patel H, Predtechenska O, et al. Anti-inflammatory actions of endogenous and exogenous interleukin-10 versus glucocorticoids on macrophage functions of the newly born [J]. J Perinatol, 2014, 34(5): 380-385. [24] Grondal G, Gunnarsson I, Ronnelid J, et al. Cytokine production, serum levels and disease activity in systemic lupus erythematosus [J]. Clin Exp Rheumatol, 2000, 18(5): 565-570. [25] Jacob SE, Nassiri M, Kerdel FA, et al. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity [J]. Mediators Inflamm, 2003, 12(5): 309-313. |
[1] | ZHANG Qian, QIN Mingming, HE Xuejia, CAI Qiujing, ZHANG Yamin, LI Qingsu, ZHU Weiwei. Effects of calcitriol on EMT induced by TGF-β1 in asthma [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 10-18. |
[2] | NIU Jiyuan, WANG Fangli, ZHANG Ruibin, GAO Qingzhen, YUN Ping, WANG Qi, ZHANG Shan, BAI Xue, WANG Xiaoping. Effect of local slow-release coated sirolmus on fistula neointimal hyperplasia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 17-21. |
[3] | TIAN Yan, HOU Shanrong, LIU Jianli, SUN Xingsheng, HUANG Lihong. Effects of different doses of atorvastatin on the content of TGF-β1 and cardiac structure of dilated cardiomyopathy rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(9): 6-10. |
[4] | WAN Bing,ZHENG Jin-xu,HUANG Xin-jian,YAN Yu-lan,WU Jian-nong. Effect of Urokinase on bleomycin-induced pulmonary fibrosis and the expression of transforming growth factor-β1 in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(12): 1243-1246. |
|